Disease · MONDO_0000262
otomycosis
6 sourcesdiseases-2026-09-18-0.1.0
Cite this record
ConductScience Library. otomycosis. Diseases, record MONDO_0000262. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0000262
On this page
Disease
Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.
Drugs7
The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Drug | ChEMBL ID | Type | Open Targets' stage | Stage reported by | Reports | Of them trials | Trials shown here | Source |
|---|---|---|---|---|---|---|---|---|
| CLOTRIMAZOLE | CHEMBL104 | Small molecule | Phase 3 | ClinicalTrials.gov | 5 | 5 | 5 | Drugs and targets |
| MICONAZOLE | CHEMBL91 | Small molecule | Phase 3 | ClinicalTrials.gov | 3 | 3 | 3 | Drugs and targets |
| POVIDONE-IODINE | CHEMBL1201724 | Phase 1 | ClinicalTrials.gov | 2 | 2 | 2 | Drugs and targets | |
| NYSTATIN | CHEMBL5465559 | Early phase 1 | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets | |
| BORIC ACID | CHEMBL42403 | Small molecule | Unknown | ClinicalTrials.gov | 3 | 3 | 3 | Drugs and targets |
| SALICYLIC ACID | CHEMBL424 | Small molecule | Unknown | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
| TERBINAFINE HYDROCHLORIDE | CHEMBL1200832 | Small molecule | Unknown | ClinicalTrials.gov | 1 | 1 | 1 | Drugs and targets |
Targets0
The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.
None in this release.
Trials11
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs.
| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04432376 | Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis) | Phase 2/3 | 382 | 2022-11-04 | Otomycosis | MICONAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT01993823 | Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis | Phase 3 | 190 | 2017-02-13 | Otomycosis | CLOTRIMAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT03130738 | Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis | Phase 2 | 65 | 2020-05-08 | Otomycosis | MICONAZOLE | Its record names the disease | ClinicalTrials.gov |
| NCT01547221 | Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients | Not applicable | 120 | Otomycosis | BORIC ACID, CLOTRIMAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT05660382 | Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis | Phase 3 | 112 | Otomycosis | MICONAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT04824261 | Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients. | Not applicable | 100 | Otomycosis | BORIC ACID, CLOTRIMAZOLE | Its record names the disease | ClinicalTrials.gov | |
| NCT06339294 | Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis Treatment | Phase 1 | 90 | Otomycosis | CLOTRIMAZOLE, POVIDONE-IODINE | Its record names the disease | ClinicalTrials.gov | |
| NCT07295210 | Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis | Not applicable | 60 | Otomycosis | BORIC ACID, POVIDONE-IODINE | Its record names the disease | ClinicalTrials.gov | |
| NCT07535424 | Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in Otomycosis | Not applicable | 60 | Otomycosis | CLOTRIMAZOLE, SALICYLIC ACID | Its record names the disease | ClinicalTrials.gov | |
| NCT07152327 | Terbinafine Hydrochloride for the Treatment of Otomycosis | Not applicable | 50 | Otomycosis, Fungal Ear Infection | TERBINAFINE HYDROCHLORIDE | Its record names the disease | ClinicalTrials.gov |
1 to 10 of 11
See all 11 trialsComparisons in its trials1
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial |
|---|---|---|---|---|
| G238 vs Clotrimazole: serious adverse events | 0 of 89 | 0 of 85 | 174 | NCT01993823 |
Source Trial comparisons
Papers from its trials7
The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Data dates
The date of each source this release read.
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this disease from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0000262
GET https://conductscience.org/api/diseases/v1/MONDO_0000262/drugs